Cargando…

Ubiquitin‐specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF‐κB pathway inactivation

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is one of the most prevalent malignant diseases in the urinary system with more than 140,000 related deaths annually. Ubiquitination–deubiquitination homeostasis is an important factor in ccRCC progression; ubiquitin‐specific peptidase 53 (USP53) b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gui, Dingwen, Dong, Zhufeng, Peng, Wei, Jiang, Weidong, Huang, Geng, Liu, Gang, Ye, Zhihua, Wang, Yang, Xu, Zuwei, Fu, Jinlun, Luo, Shuai, Zhao, Yunfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178486/ https://www.ncbi.nlm.nih.gov/pubmed/33973730 http://dx.doi.org/10.1002/cam4.3911

Ejemplares similares

Deubiquitination and stabilization of programmed cell death ligand 1 by ubiquitin‐specific peptidase 9, X‐linked in oral squamous cell carcinoma
por: Jingjing, Wu, et al.
Publicado: (2018)

Ubiquitin specific peptidases and prostate cancer
por: Guo, Yunfei, et al.
Publicado: (2023)

Ubiquitin-specific peptidase 2 inhibits epithelial-mesenchymal transition in clear cell renal cell carcinoma metastasis by downregulating the NF-κB pathway
por: Duan, Jiachen, et al.
Publicado: (2022)

Ubiquitin specific peptidase 19 is a prognostic biomarker and affect the proliferation and migration of clear cell renal cell carcinoma
por: Hu, Wenbing, et al.
Publicado: (2020)

Knockdown of ubiquitin-specific peptidase 39 inhibited the growth of osteosarcoma cells and induced apoptosis in vitro
por: Gan, Zhihua, et al.
Publicado: (2017)

Ubiquitin specific peptidase Usp53 regulates osteoblast versus adipocyte lineage commitment
por: Hariri, Hadla, et al.
Publicado: (2021)

Influence of gene expression on survival of clear cell renal cell carcinoma
por: Berglund, Anders, et al.
Publicado: (2020)

Ubiquitin-specific peptidase 18 regulates the differentiation and function of Treg cells
por: Yang, Lu, et al.
Publicado: (2020)

Circadian clock is associated with tumor microenvironment in kidney renal clear cell carcinoma
por: Zhou, Liangcheng, et al.
Publicado: (2020)

Tumor signatures of PTHLH overexpression, high serum calcium, and poor prognosis were observed exclusively in clear cell but not non clear cell renal carcinomas
por: Yao, Masahiro, et al.
Publicado: (2014)

E3 Ubiquitin ligase RNF126 regulates the progression of tongue cancer
por: Wang, Lina, et al.
Publicado: (2016)

The role of ubiquitin-specific peptidases in cancer progression
por: Young, Ming-Jer, et al.
Publicado: (2019)

Expression and Role of Ubiquitin-Specific Peptidases in Osteoblasts
por: Hariri, Hadla, et al.
Publicado: (2021)

Ubiquitin‐specific peptidases: Players in bone metabolism
por: Shen, Jianlin, et al.
Publicado: (2023)

Dehydroeffusol inhibits hypoxia-induced epithelial–mesenchymal transition in non-small cell lung cancer cells through the inactivation of Wnt/β-catenin pathway
por: Wei, Haitao, et al.
Publicado: (2020)

CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
por: Arakaki, Ryuichiro, et al.
Publicado: (2016)

Etiologic heterogeneity of clear‐cell and papillary renal cell carcinoma in the Netherlands Cohort Study
por: van de Pol, Jeroen A. A., et al.
Publicado: (2020)

Characterizing Tumor Thrombus Arising from Non–Clear Cell Renal Cell Carcinoma
por: Rabinowitz, Matthew J., et al.
Publicado: (2022)

Implications of ubiquitination and the maintenance of replication fork stability in cancer therapy
por: Xia, Donghui, et al.
Publicado: (2023)

IKKα plays a major role in canonical NF-κB signalling in colorectal cells
por: Prescott, Jack A., et al.
Publicado: (2022)

p53 is functionally inhibited in clear cell renal cell carcinoma (ccRCC): a mechanistic and correlative investigation into genetic and molecular characteristics
por: Diesing, Karoline, et al.
Publicado: (2021)

Ubiquitin-specific peptidase 37: an important cog in the oncogenic machinery of cancerous cells
por: Chauhan, Ravi, et al.
Publicado: (2021)

LncRNA HAND2-AS1 inhibits proliferation and promotes apoptosis of non-small cell lung cancer cells by inactivating PI3K/Akt pathway
por: Gao, Ting, et al.
Publicado: (2020)

Inactivation of oncogenic cAMP-specific phosphodiesterase 4D by miR-139-5p in response to p53 activation
por: Cao, Bo, et al.
Publicado: (2016)

Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
por: Gulati, Sakshi, et al.
Publicado: (2014)

First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape
por: Gulati, Shuchi, et al.
Publicado: (2022)

Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy
por: Li, Xiaolei, et al.
Publicado: (2017)

Inhibition of NEDD8 NEDDylation induced apoptosis in acute myeloid leukemia cells via p53 signaling pathway
por: Chen, Yanli, et al.
Publicado: (2022)

MicroRNA-202 inhibits cell migration and invasion through targeting FGF2 and inactivating Wnt/β-catenin signaling in endometrial carcinoma
por: Chen, Ping, et al.
Publicado: (2019)

Correction: Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy
por: Li, Xiaolei, et al.
Publicado: (2020)

Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors
por: Chen, Shiyao, et al.
Publicado: (2021)

The role of mesenchymal stem cells in the occurrence, development, and therapy of hepatocellular carcinoma
por: Zhang, Xiaoli, et al.
Publicado: (2022)

Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma
por: Xu, Jianing, et al.
Publicado: (2019)

Preclinical evaluation of an unconventional ruthenium‐gold‐based chemotherapeutic: RANCE‐1, in clear cell renal cell carcinoma
por: Elie, Benelita T., et al.
Publicado: (2019)

Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma
por: Zarrabi, Kevin K, et al.
Publicado: (2022)

Hepatocellular carcinoma after a sustained virological response by direct‐acting antivirals harbors TP53 inactivation
por: Imamura, Taisuke, et al.
Publicado: (2022)

Ubiquitin-specific peptidase 22 controls integrin-dependent cancer cell stemness and metastasis
por: Liu, Kun, et al.
Publicado: (2023)

Ubiquitination in melanoma pathogenesis and treatment
por: Ma, Jinyuan, et al.
Publicado: (2017)

Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm
por: Luo, Jun, et al.
Publicado: (2020)

Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials
por: Friedlander, Michael L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ugaoor8pa8j71m2ubmcn6fj5bk